Company type | Public | ||||
---|---|---|---|---|---|
Industry |
| ||||
Founded |
| ||||
Headquarters | Guangzhou , China | ||||
Key people |
| ||||
Brands |
| ||||
Revenue | CN¥1.862 billion (2016) | ||||
CN¥ 59 million (2016) | |||||
CN¥ 66 million (2016) | |||||
Total assets | CN¥7.989 billion (2016) | ||||
Total equity | CN¥3.397 billion (2016) | ||||
Owner | Wang Yonghui couple (36.98%) | ||||
Footnotes / references in consolidated financial statement[2] |
Xiangxue Pharmaceutical Co., Ltd. | |||||||
---|---|---|---|---|---|---|---|
Simplified Chinese | 广州市香雪制药股份有限公司 | ||||||
Literal meaning | Guangzhou City Xiangxue Pharmaceutical, Company Limited by Shares | ||||||
| |||||||
Xiangxue Pharmaceutical | |||||||
Simplified Chinese | 香雪制药 | ||||||
Traditional Chinese | 香雪製葯[nb 1] | ||||||
|
Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue (now in the Luogang Subdistrict, Huangpu District), thus called itself Xiangxue (Chinese: 香雪; pinyin: Xiāng xuě; Jyutping: hoeng1 syut3; lit. 'Fragrant Snow').
Xiangxue Pharmaceutical was a constituent of SZSE 200 Index (mid-cap index), but was removed in January 2017; it was inserted to SZSE 700 Index (small-cap index) instead at the same time.[3][4] SZSE 200, 300 and 700 Indexes are subsets of SZSE 1000 Index, the latter is a stock market index for the top 1,000 companies by free-float adjusted capitalization. In July 2017 Xiangxue was also removed from SZSE Component Index, an index for top 500 companies of the exchange.[5][6]
Xiangxue2016AR
was invoked but never defined (see the help page).
Cite error: There are <ref group=nb>
tags on this page, but the references will not show without a {{reflist|group=nb}}
template (see the help page).